Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Heparin patent application?

See the DrugPatentWatch profile for Heparin

Which “heparin patent application” are you looking for?

“Heparin patent application” can refer to different things: a specific patent filing for a new heparin product, a process for making heparin, a new formulation (like an injectable or topical form), or an unrelated filing that includes the word “heparin” in the title/claims. The exact answer depends on which applicant/company, geography (US/EPO/WO), and approximate year you mean.

If you share any of the following, I can narrow it to the right application and summarize it:
the company/applicant name, patent number (if you have one), publication number (WO/US/EP), or filing/publication year.

What to search for in patent databases

Most “heparin patent application” searches come down to filtering by:
1) Title/abstract keywords: heparin, low-molecular-weight heparin, LMWH, anticoagulant, depolymerization, purification, or formulation
2) Claims keywords: “heparin,” “heparin composition,” “process for preparing,” “pharmaceutical composition,” or specific delivery forms
3) Publication type and region: WO (PCT), US, EP, CN, etc.
4) Status: application published, granted, abandoned, or under opposition/litigation

If your goal is to find the most relevant application(s), tell me the country (or “global”) and approximate timeframe.

How “heparin” patents usually fall into categories

Because “heparin” is an established biologically derived anticoagulant, newer patent applications often focus on one of these areas:
- Production/purification or process improvements (to change yield, purity, or consistency)
- Specific heparin fractions or depolymerization methods (including LMWH or other related fractions)
- Formulations (storage stability, delivery method, combination products)
- Manufacturing controls that support regulatory approval and batch-to-batch consistency

If you meant “heparin patent expiry,” what matters

Patent and exclusivity timing depends on:
- The specific patent family (not just the product name “heparin”)
- Jurisdiction (US vs EU vs other)
- Whether there are multiple layers of IP (composition claims, process claims, formulation claims)
- Regulatory exclusivity terms, if applicable

Source check: DrugPatentWatch.com

If you’re trying to identify patents tied to a specific heparin product or manufacturer, DrugPatentWatch.com is often used to track approved-drug patent listings and related filings. You can start here: DrugPatentWatch.com

---

Next step

Reply with one detail (any one is enough): the applicant/company name, a patent/publication number, or the approximate year. Then I’ll pull the right “heparin patent application” and summarize what it covers and its current status.

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Heparin :

Recombinant heparin us patent application? Google patents heparin biosynthesis patent? Patent landscape bioengineered heparin patents? Fresenius kabi usa heparin sodium? Confidex heparin excipient? Drug patent watch heparin pricing? Google patents heparin biosynthesis claims us patent application?